MetaCap

Amgen Statistics

NASDAQ: AMGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

435.64-0.66 (-0.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Amgen by the numbers

Amgen has a market capitalization of $235.64 billion based on 540.91M shares outstanding. Its trailing P/E ratio is 25.3, below the 4-company peer median of 27.2, and its forward P/E is 17.3. The stock trades 1.2% above its 50-day average and 13.6% above its 200-day average.

Average daily trading volume is 2.82M shares, or about $1.23 billion in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

AMGN valuation vs. peer median

AMGN compared with the median of 8 peer companies
MetricAMGNPeer medianDifference
Market cap$235.64B$35.88B+557%
P/E (TTM)25.327.2-7%
Forward P/E17.315.4+13%
Avg. volume2.82M1.81M+56%

Peer median across 8 companies: GILD, MRNA, ARGX, BIIB, RVMD, BNTX, EXEL, NBIX.

Valuation

Market cap
$235.64B
Price / sales (latest FY)
6.41
EPS (TTM)
$17.25

Price and trading

Previous close
436.30
Open
443.05
Day range
434.51 – 445.49
52-week range
312.39 – 483.99
52-week change
+29.06%
Beta
—
Volume
4.94M

Dividends and events

Annual dividend
$9.94

Additional statistics

Market Cap
235.64B
Pe
25.25
Forward Pe
17.34
Eps
17.25
Dividend Yield
2.31%
Dividend Rate
9.94
Week52 High
483.99
Week52 Low
312.39
Avg Volume
2.82M
Shares Outstanding
540.91M
Ma50
430.45
Ma200
383.40
Earnings Date
Nov 3, 2026
Pct From52w High
-9.99%
Pct From52w Low
39.45%

Related